Q
Qubit Pharmaceuticals
Biotech & Life Sciences · Paris, France · Founded 2020
Quantum physics and AI-driven drug discovery platform MoreLess
Developer of drug discovery simulation platform designed to reduce the cost and length of preclinical drug development. The company's platform uses proprietary force field models and molecular dynamics calculations and performs virtual screening, and visualization, to find valuable candidates, enabling biopharmaceutical companies to get support in their research and development by accelerating drug discovery with quantum physics. Keywords: Software, Fintech, Security and Connectivity, Drug Development System, Drug Development Tool, Drug Discovery Platform, Drug Discovery Software, Drug Discovery Technology, Hpc Software, Machine Learning Solutions, Quantum Computing Application.
Company overview
Qubit Pharmaceuticals company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2020
- Headquarters
- Paris, France
- Employees
- 60
- Open positions
- None listed
- Dealroom signal
- 61.2
Valuation & funding
Qubit Pharmaceuticals funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Jun 2022 | $18M | $70M | Octave Klaba · Quantonation · Omnes Capital · XAnge | ↗ |
| GRANT✓Other financing | Jun 2021 | $2.5M | — | European Innovation Council | — |
| EARLY VC✓Equity / VC | Jun 2021 | $5.5M | $22M | EIC Fund | — |
| SUPPORT PROGRAM✓Other financing | Jun 2020 | $44K | — | EIT Health | — |
| SPINOUT✓Other financing | Apr 2020 | — | — | French National Centre for Scientific Research - CNRS · CNRS Innovation · SATT LUTECH · Sorbonne University | ↗ |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 57 |
| 2025 | 65 |
| 2024 | 65 |
| 2023 | 57 |
| 2022 | 31 |
Growth signals
Qubit Pharmaceuticals website traffic
Latest recorded traffic for Qubit Pharmaceuticals is 6.1K monthly website visits, up 110.3% over the last three months. Qubit Pharmaceuticals's team declined 7.7% over the past year.
Comparisons
Qubit Pharmaceuticals compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Qubit Pharmaceuticals's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Qubit Pharmaceuticals has talent and traffic
team presence
In the news
Latest news about Qubit Pharmaceuticals
Recent press, funding announcements, and product moves mentioning Qubit Pharmaceuticals — open to read from the original sources.
Market sentiment
What the market is saying about Qubit Pharmaceuticals
An AI-synthesized read of the highest-engagement posts about Qubit Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Qubit Pharmaceuticals’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.